InVitro International
OTC: IVRO0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Other OTC
- Sector
- Healthcare
- Industry
- Medical - Diagnostics & Research
- CEO
- W. Richard Ulmer
- Employees
- 6
- Headquarters
- Placentia, United States
- IPO year
- 1991
- Market cap
- $1.9M
- Website
- https://www.invitrointl.com
Loading IVRO…
Loading profile data…Frequently asked questions about IVRO
What does InVitro International (IVRO) do?
Established in 1985 and headquartered in Placentia, California, InVitro International specializes in creating and supplying non-animal testing kits to markets both within the United States and globally. Key among their offerings is the Irritection Assay System, an in vitro diagnostic tool designed to identify, categorize, and forecast the potent...
Where does IVRO trade?
InVitro International (IVRO) trades on the Other OTC.
What sector is IVRO in?
InVitro International (IVRO) operates in the Healthcare sector, specifically in the Medical - Diagnostics & Research industry.
Who is the CEO of InVitro International?
W. Richard Ulmer is the chief executive officer of InVitro International (IVRO).
Where is InVitro International headquartered?
InVitro International is headquartered in United States.
Does IVRO pay a dividend?
InVitro International (IVRO) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did IVRO go public?
InVitro International (IVRO) completed its initial public offering in 1991.